Powered by
Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017

Click to Tweet

Flex Pharma, Inc . (NASDAQ: FLKS), abiotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT), announced todaythat it will report its financial results for the fourth quarter and year ended December 31, 2016 on Wednesday, March 8, 2017 before the U.S. financial markets open. The Company will host a conference cal

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox